Professor Amanj Kurdi is Professor of Pharmacoepidemiology and Pharmacy Practice at the University of Strathclyde. His research focuses on the generation and application of real world evidence to evaluate the utilisation, effectiveness, safety, and value of medicines and healthcare interventions, with the aim of informing clinical practice, health policy, and regulatory decision making.

His work spans pharmacoepidemiology, drug utilisation research, medicines optimisation, medication safety, antimicrobial stewardship, and health services research. He has extensive expertise in the analysis of large-scale routinely collected healthcare data, including linked electronic health records, prescribing databases, hospital datasets, and national population-level resources. Using advanced epidemiological, statistical, and data science methods, his research examines prescribing quality, medication adherence and persistence, treatment outcomes, and the impact of health policies and clinical guidelines across a range of therapeutic areas.

Professor Kurdi has particular interests in antimicrobial resistance (AMR), antimicrobial stewardship, cardiovascular disease, diabetes, biologics and specialist medicines, and the use of real world data to support post-marketing surveillance and medicines safety monitoring. He leads and collaborates on national and international projects involving big data analytics, health informatics, and population health research, working closely with healthcare providers, policymakers, regulators, and academic partners.

He actively collaborates with researchers and institutions across the UK and internationally and contributes to several multidisciplinary research networks and initiatives. Through his research, he aims to improve the quality, safety, and sustainability of healthcare while strengthening the evidence base that supports medicines use and health policy decisions.